Stroke Trial, Recruiting (NCT06804304)

Stroke Trial, Recruiting NCT06804304 Sponsor: Teppo Sarkamo Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06804304 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a stroke in either the left or right side of the brain, at least 3 months ago
People who have at least mild difficulty with thinking and memory, and either mild difficulty with speech and language or mild weakness in one arm, as a result of the stroke
People aged between 30 and 80 years old
People who speak Finnish, or who are bilingual and able to participate in Finnish
People who understand what the study involves and are able to give their consent to take part

Who may not be able to join:

People who had significant hearing or vision problems before the stroke
People who had a serious mental health condition before the stroke, such as schizophrenia, bipolar disorder, or severe depression
People who had a serious brain or neurological condition before the stroke, such as a brain injury or dementia (having had a previous mild stroke or TIA may still be acceptable — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Teppo Särkämö, Ph.D., University of Helsinki / Faculty of Medicine / Department of Psychology

Phone: +358505399065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06804304

Sponsor: Teppo Sarkamo

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +358505399065

More information: https://clinicaltrials.gov/study/NCT06804304

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a stroke in either the left or right side of the brain, at least 3 months ago
People who have at least mild difficulty with thinking and memory, and either mild difficulty with speech and language or mild weakness in one arm, as a result of the stroke
People aged between 30 and 80 years old
People who speak Finnish, or who are bilingual and able to participate in Finnish
People who understand what the study involves and are able to give their consent to take part

Who may not be able to join:

People who had significant hearing or vision problems before the stroke
People who had a serious mental health condition before the stroke, such as schizophrenia, bipolar disorder, or severe depression
People who had a serious brain or neurological condition before the stroke, such as a brain injury or dementia (having had a previous mild stroke or TIA may still be acceptable — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Teppo Sarkamo

Registry

ClinicalTrials.gov

Start date

1 February 2025

Est. completion

1 June 2028

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Change in the cognitive functioning summary score from baseline to 3-month stage; Change in the speech production summary score from baseline to 3-month stage; Change in the upper-extremity motor function summary score from baseline to 3-month stage; Change in the mood and quality of life summary score from baseline to 3-month stage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov